Literature DB >> 31292819

Novel findings in enhanced S-cone syndrome: a case with macular retinal neovascularization and severe retinal vasculitis.

Fatemeh Bazvand1, Hasan Khojasteh1, Mohammad Zarei2.   

Abstract

PURPOSE: To describe a novel association of enhanced S-cone syndrome (ESCS) with macular retinal neovascularization and severe retinal vasculitis.
METHODS: Clinical examination, spectral domain optical coherence tomography, fluorescein angiography, fundus autofluorescence, infrared reflectance and electroretinography were used to study a 25-year-old male with a history of night blindness from early childhood and recent accelerated visual loss in right eye.
RESULTS: Pigmented lesions were observed along the arcades without peripheral retinal involvement. Intraretinal cystoid spaces, retinal neovascularization of posterior pole and severe peripheral and posterior retinal vasculitis were found on clinical examination and multimodal imaging. Based on characteristic clinical and electroretinographic findings, a diagnosis of ESCS was made.
CONCLUSION: This case highlights novel associations of retinal neovascularization and vasculitis with ESCS.

Entities:  

Keywords:  Electroretinography; Enhanced S-cone syndrome; Neovascularization; Retinal vasculitis

Year:  2019        PMID: 31292819     DOI: 10.1007/s10633-019-09706-6

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  14 in total

Review 1.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

2.  Bilateral optic disc neovascularization in association with retinitis pigmentosa.

Authors:  K W To; A J Nadel; S H Perlstein; S Margolis
Journal:  Can J Ophthalmol       Date:  1991-04       Impact factor: 1.882

3.  Choroidal neovascularization, outer retinal tubulation and fundus autofluorescence findings in a patient with enhanced S-cone syndrome.

Authors:  Javier Sambricio; Pilar Tejada-Palacios; Ana Barceló-Mendiguchía
Journal:  Clin Exp Ophthalmol       Date:  2015-07-30       Impact factor: 4.207

4.  ISCEV Standard for full-field clinical electroretinography (2015 update).

Authors:  Daphne L McCulloch; Michael F Marmor; Mitchell G Brigell; Ruth Hamilton; Graham E Holder; Radouil Tzekov; Michael Bach
Journal:  Doc Ophthalmol       Date:  2014-12-14       Impact factor: 2.379

5.  The negative coincidence of retinitis pigmentosa and proliferative diabetic retinopathy.

Authors:  P Sternberg; M B Landers; M Wolbarsht
Journal:  Am J Ophthalmol       Date:  1984-06       Impact factor: 5.258

6.  Retinitis pigmentosa associated with peripheral sea fan neovascularization.

Authors:  S Kadayifçilar; B Eldem; H Kiratli
Journal:  Acta Ophthalmol Scand       Date:  2000-10

7.  SWS (blue) cone hypersensitivity in a newly identified retinal degeneration.

Authors:  S G Jacobson; M F Marmor; C M Kemp; R W Knighton
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-05       Impact factor: 4.799

8.  Expanded clinical spectrum of enhanced S-cone syndrome.

Authors:  Suzanne Yzer; Irene Barbazetto; Rando Allikmets; Mary J van Schooneveld; Arthur Bergen; Stephen H Tsang; Samuel G Jacobson; Lawrence A Yannuzzi
Journal:  JAMA Ophthalmol       Date:  2013-10       Impact factor: 7.389

9.  Bevacizumab for choroidal neovascularisation in enhanced S-cone syndrome.

Authors:  G K Broadhead; J R Grigg; P McCluskey; M Korsakova; A A Chang
Journal:  Doc Ophthalmol       Date:  2016-07-16       Impact factor: 2.379

10.  Retinitis pigmentosa reduces the risk of proliferative diabetic retinopathy: a nationwide population-based cohort study.

Authors:  Yuh-Fang Chen; Hsin-Yi Chen; Che-Chen Lin; Muh-Shy Chen; Pei-Chun Chen; I-Jong Wang
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.